APEX BIOTECHNOLOGY CORPORATION – Trademark Portfolio
Entity Type: 03
APEX BIOTECHNOLOGY CORPORATION holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include APEXBIO, GLUCOSURE, HEMOSMART, and GLUCOCLOUD. The owner is based in Hsinchu City.
No. 7
Li-Hsin Rd. V, Hsinchu Science Park
Hsinchu City 30078 , TW
Showing of trademarks Trademarks
Trademark Classifications
APEX BIOTECHNOLOGY CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does APEX BIOTECHNOLOGY CORPORATION have?
APEX BIOTECHNOLOGY CORPORATION has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does APEX BIOTECHNOLOGY CORPORATION file in?
APEX BIOTECHNOLOGY CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are APEX BIOTECHNOLOGY CORPORATION's most well-known trademarks?
APEX BIOTECHNOLOGY CORPORATION's registered trademark portfolio includes well-known marks such as APEXBIO, GLUCOSURE, HEMOSMART, and GLUCOCLOUD. These are among 7 currently registered trademarks in the portfolio.
What is APEX BIOTECHNOLOGY CORPORATION's trademark registration success rate?
APEX BIOTECHNOLOGY CORPORATION has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.